Newsletter | April 5, 2024

Best of March: Top 5 Insights In Clinical Trial Technology

Clinical Tech Leader

TOP 5 INSIGHTS IN CLINICAL TRIAL TECHNOLOGY
MARCH EDITION

#1 - It's Hard To Predict AI's Real Value To Clinical Trials

At the time of writing this article, Sunny Kumar, a partner at GSR Ventures, was planning to talk about AI and ML use in clinical trials during the SCOPE Summit panel, The Future of Clinical Trial Tech: Perspectives from Different Investors.

#2 - With The Emergence Of DCTs, Do We Really Need A CTMS?

As decentralized trial designs continue to grow in popularity, do sponsors and CROs really need a clinical trial management system? Explore whether CTMSisstill necessary with the emergence of decentralized clinical trials.

#3 - 9 Ways Unified Clinical Data Cloud Platforms Solve Data Challenges In Rare Disease

A unified clinical data cloud platform contains a data hub to aggregate clinical data from multiple data sources and in multiple formats — and it could be the cure for disordered rare disease data.

#4 - Rave Companion: Accelerate EDC Data Entry For Your Sites

Discover how you and your sites can benefit from Rave Companion, an easy-to-set-up and user-friendly tool that fits right into existing data entry workflows, ensuring simpler, quicker, and more accurate data entry.

#5 - eCOA Solutions: Trends, Benefits, & Buying In 2024

The eCOA solution market is anticipated to capture $15.1 billion by the year 2036, growing at a CAGR of almost 15.1% during the forecast period. Learn more with this market outlook.